We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
(-9.9%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-24.44%
Top 10 Holdings %
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$59.4M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$56.3M |
| 3 |
Simon Property Group
SPG
|
+$52M |
| 4 |
TSMC
TSM
|
+$45.4M |
| 5 |
Macy's
M
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$167M |
| 2 |
GDI
GARDNER DENVER,INC
GDI
|
+$60.4M |
| 3 |
BMC
BMC SOFTWARE, INC
BMC
|
+$58.7M |
| 4 |
SFD
SMITHFIELD FOODS,INC
SFD
|
+$55.2M |
| 5 |
Advance Auto Parts
AAP
|
+$48.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 14.75% |
| 2 | Consumer Staples | 11.78% |
| 3 | Consumer Discretionary | 6.16% |
| 4 | Financials | 6.01% |
| 5 | Industrials | 5.28% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q3 2013 Portfolio in Review
As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.
- UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
- UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
- UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
- UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
- UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
- UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
- UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.
Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.